Catalyst Wire Dossier Catalyst Wire Dossier

Fianlimab

fianlimab · Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

26 regulatory and trial events tracked for Fianlimab, covering 2024-07-26 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma [Phase 2]

See pricing